DUBLIN, IRELAND – November 1, 2017 – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today announced the opening of a new corporate office in Dublin, further establishing the Company’s presence in Ireland. The Company plans to expand its Dublin employee base by hiring 30 highly-skilled professionals over the next two years in in areas such as clinical development, finance, and technical operations. An Tánaiste and Minister for Business, Enterprise and Innovation Frances Fitzgerald TD and other IDA Ireland executives joined members of the Theravance Biopharma board of directors and employees at the opening ceremony.
The Australian Venom Zoo’s main principle is to teach the public more about venomous animals and how we are incorporating this into work with bio-pharmaceutical companies.
All of the Venom that is supplied from the Australian Venom Zoo, goes towards developing the worlds most cutting edge medicines, through molecular biology. We tell people on a tour of the zoo that the top 65% of medicines or drugs are derived from Botany right now.
Within the next 5 to 10 years, all of the cutting edge medicines will be created using venom or biology.
This is not a new concept though since Indigenous people all throughout the world have been using these as medicines for thousands of years.
We aim to educate the general public that their are some great things being developed because of the deadliest animals in the world.
In the United States , biologics are regulated by the FDA's Center for Biologics Evaluation and Research (CBER) whereas drugs are regulated by the Center for Drug Evaluation and Research . Approval may require several years of clinical trials , including trials with human volunteers. Even after the drug is released, it will still be monitored for performance and safety risks. The manufacture process must satisfy the FDA's "Good Manufacturing Practices", which are typically manufactured in a clean room environment with strict limits on the amount of airborne particles.